BIRC5 and breast cancer: We discovered that treating the highly aggressive MDAMB231 breast cancer cell line with PTX not only increased the amount of exosomes that these cells generated, but it also caused an enrichment in the amount of Survivin present as cargo in the vesicles, an effect that had important functional consequences.